GlaxoSmithKline PLC Director/PDMR Shareholding (2016L)
29 September 2016 - 7:17PM
UK Regulatory
TIDMGSK
RNS Number : 2016L
GlaxoSmithKline PLC
29 September 2016
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================
a) Name Dr K Slaoui
=== ========================= ========================================
b) Position/status PCA of Dr M M Slaoui (Chairman, Global
Vaccines)
=== ========================= ========================================
c) Initial notification/ Initial notification
amendment
=== ========================= ========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================
a) Name GlaxoSmithKline plc
=== ========================= ========================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================
a) Description of GlaxoSmithKline plc American Depositary
the financial Shares ('ADSs')
instrument ISIN: US37733W1053
=== ========================= ========================================
b) Nature of the Award of ADSs under the Company's 2009
transaction Share Value Plan
=== ========================= ========================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
$43.58 2,300
--------- ----------
=== ========================= ========================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ========================= ========================================
e) Date of the transaction 2016-09-22
=== ========================= ========================================
f) Place of the n/a
transaction
=== ========================= ========================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ======================================================================
a) Name Mrs V A Whyte
=== ======================== ============================================
b) Position/status Company Secretary
=== ======================== ============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ======================== ============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each 'Ordinary
the financial Shares'
instrument ISIN: GB0009252882
=== ======================== ============================================
b) Nature of the Award of Ordinary Shares under the Company's
transaction 2009 Share Value Plan
=== ======================== ============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ---------- ----------
GBP16.49 11,060
---------- ----------
=== ======================== ============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ============================================
e) Date of the transaction 2016-09-22
=== ======================== ============================================
f) Place of the n/a
transaction
=== ======================== ============================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHKKLBLQKFFBBZ
(END) Dow Jones Newswires
September 29, 2016 05:17 ET (09:17 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024